Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism (The ARTIST Study)
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The registry is to evaluate the safety and feasibility of catheter-directed aspiration for patients with high-risk and intermediate-high-risk pulmonary embolism using Acostream.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:
• 18≤Age≤85
• Clinical symptoms and presentation consistent with pulmonary embolism (PE).
• PE symptoms duration ≤ 14 days.
• High risk PE patients with absolute contraindications to systemic thrombolysis or its failure (refractory circulatory collapse) not eligible for surgical embolectomy.
• Intermediate-high risk PE patients with right ventricle dysfunction (right ventricle/ left ventricle \>0.9) confirmed by computed tomography pulmonary angiography or transthoracic echocardiography.
Locations
Other Locations
China
Renji Hospital
RECRUITING
Shanghai
Contact Information
Primary
Qihong Ni
niqihong1989@163.com
15801900772
Backup
Meng Ye
13817145123@163.com
13817145123
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 127
Treatments
Experimental: The Acostream aspiration group
The pulmonary thrombus removal by Acostream.
Related Therapeutic Areas
Sponsors
Collaborators: Jinhua Central Hospital, Xiamen Cardiovascular Hospital, Xiamen University, Chengdu University of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, Shanghai No.1 Hospital, Nantong University Affiliated Hospital
Leads: RenJi Hospital